| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 1,148,711 | 1,128,468 | 1,054,120 | 1,163,565 | | Cost of Revenue | (1,009,031) | 1,009,031 |
-
| 508,563 | | | Gross Profit | 2,157,742 | 119,437 | 1,054,120 | 655,002 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,994,261 | 22,488 | 989,098 | 440,133 | | Non Recurring | 25,387 |
-
|
-
| 135,439 | | Others | 76,861 | 90,768 | 84,628 | 17,174 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 61,233 | 6,181 | (19,606) | 62,256 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 658 | 20,194 | (3,235) | 13,047 | | Earnings Before Interest And Taxes | 34,699 | 26,169 | (23,603) | 76,971 | | Interest Expense | 7,533 | 7,701 | 7,880 | 5,144 | | Income Before Tax | 27,166 | 18,468 | (31,483) | 71,827 | | Income Tax Expense | 10,100 | 7,100 | (12,000) | 53,000 | | Minority Interest | 214 | 1,894 |
-
|
-
| | | | Net Income From Continuing Ops | (10,880) | 13,262 | (19,483) | 18,827 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 17,280 | 13,262 | (19,483) | 18,827 | | Preferred Stock And Other Adjustments | (230) | (1,013) | 315 |
-
| | | Net Income Applicable To Common Shares | $17,050 | $12,249 | ($19,168) | $18,827 |
|
0.02% Nasdaq 
0.10 (0.02%) 
Income Statement
